48 related articles for article (PubMed ID: 20097367)
1. Epidermal growth factor receptor as a target for anti-proliferative treatment of proliferative cholangitis in hepatolithiasis.
Li F; Zhou Y; Cheng N; Mao H; Jiang L; Li N; Li Q; de Jong MC; Pawlik TM
J Surg Res; 2011 Mar; 166(1):87-94. PubMed ID: 20097367
[TBL] [Abstract][Full Text] [Related]
2. Practical value of applying cdc2 kinase shRNA to chronic proliferative cholangitis in treatment of hepatolithiasis.
Li FY; Cheng NS; Cheng JQ; Mao H; Jiang LS; Li QS; Zhou Y
Hepatogastroenterology; 2009; 56(94-95):1477-82. PubMed ID: 19950813
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen shRNA treatment attenuates chronic proliferative cholangitis in rats.
Li FY; Cheng NS; Cheng JQ; Mao H; Zhou Y; Jiang LS; Li N
J Gastroenterol Hepatol; 2009 May; 24(5):920-6. PubMed ID: 19032457
[TBL] [Abstract][Full Text] [Related]
4. Effects of epidermal growth factor receptor inhibitor genistein on proliferative cholangitis in rats.
Jiang L; Jiang LS; Yan LN; Li FY; Wang W; Cheng NS; Wen TF
J Surg Res; 2010 Jul; 162(1):59-67. PubMed ID: 19665144
[TBL] [Abstract][Full Text] [Related]
5. Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis.
Yang Q; Zhou Y; Li FY; Mao H; Shrestha A; Ma WJ; Cheng NS; Zhang W
Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):509-15. PubMed ID: 26459727
[TBL] [Abstract][Full Text] [Related]
6. Suppression of proliferative cholangitis in a rat model by local delivery of paclitaxel.
Park SM; Choi JW; Kim ST; Cho MC; Sung RH; Jang LC; Park JW; Lee SP; Park YH
J Hepatobiliary Pancreat Surg; 2003; 10(2):176-82. PubMed ID: 14505153
[TBL] [Abstract][Full Text] [Related]
7. Suppression of proliferative cholangitis in a rat model with direct adenovirus-mediated retinoblastoma gene transfer to the biliary tract.
Terao R; Honda K; Hatano E; Uehara T; Yamamoto M; Yamaoka Y
Hepatology; 1998 Sep; 28(3):605-12. PubMed ID: 9731547
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic proliferative cholangitis with c-myc shRNA.
Li FY; Cheng NS; Cheng JQ; Mao H; Jiang LS; Li N; He S
World J Gastroenterol; 2009 Jan; 15(1):95-101. PubMed ID: 19115473
[TBL] [Abstract][Full Text] [Related]
9. Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide.
Yoshida M; Yamamoto N; Nitta T; Uehara T; Terao R; Hatano E; Iimuro Y; Yamaoka Y
J Surg Res; 2002 Feb; 102(2):95-101. PubMed ID: 11796004
[TBL] [Abstract][Full Text] [Related]
10. Role of epidermal growth factor receptor in maintaining airway goblet cell hyperplasia in rats sensitized to allergen.
Takeyama K; Tamaoki J; Kondo M; Isono K; Nagai A
Clin Exp Allergy; 2008 May; 38(5):857-65. PubMed ID: 18307528
[TBL] [Abstract][Full Text] [Related]
11. Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits.
Ma WJ; Wu ZR; Yang Q; Hu HJ; Wang JK; Shi YJ; Li FY; Cheng NS
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):356-367. PubMed ID: 31420296
[TBL] [Abstract][Full Text] [Related]
12. Activation of epidermal growth factor receptor during corneal epithelial migration.
Zieske JD; Takahashi H; Hutcheon AE; Dalbone AC
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1346-55. PubMed ID: 10798649
[TBL] [Abstract][Full Text] [Related]
13. Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis.
Benter IF; Canatan H; Benboubetra M; Yousif MH; Akhtar S
Vascul Pharmacol; 2009; 51(2-3):101-9. PubMed ID: 19410658
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes.
Ben-Bassat H; Rosenbaum-Mitrani S; Hartzstark Z; Shlomai Z; Kleinberger-Doron N; Gazit A; Plowman G; Levitzki R; Tsvieli R; Levitzki A
Cancer Res; 1997 Sep; 57(17):3741-50. PubMed ID: 9288782
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension.
Merklinger SL; Jones PL; Martinez EC; Rabinovitch M
Circulation; 2005 Jul; 112(3):423-31. PubMed ID: 16027270
[TBL] [Abstract][Full Text] [Related]
16. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors.
Han Y; Caday CG; Nanda A; Cavenee WK; Huang HJ
Cancer Res; 1996 Sep; 56(17):3859-61. PubMed ID: 8752145
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitors.
Brunton VG; Kelland LR; Lear MJ; Montgomery GJ; Robertson JH; Robins DJ; Queen J; Workman P
Anticancer Drug Des; 1996 Jun; 11(4):265-95. PubMed ID: 8679052
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
Kim SJ; Uehara H; Yazici S; Langley RR; He J; Tsan R; Fan D; Killion JJ; Fidler IJ
Cancer Res; 2004 Jun; 64(12):4201-8. PubMed ID: 15205332
[TBL] [Abstract][Full Text] [Related]
19. EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR.
Liu SH; Chen XF; Xie ZB; Zhou J
Int J Mol Med; 2019 Jul; 44(1):79-88. PubMed ID: 31115490
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
